The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
118058512 11805851 2 F 2015 20160429 20151207 20160810 PER US-ASTRAZENECA-2015SF19344 ASTRAZENECA 70.00 YR M Y 70.30000 KG 20160810 US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
118058512 11805851 1 PS NEXIUM ESOMEPRAZOLE MAGNESIUM 1 Oral TWO 40 MG CAPSULES, EQUALING 80MG, TWICE A DAY, TOTALING 160 21153 CAPSULE
118058512 11805851 2 SS PRILOSEC OMEPRAZOLE MAGNESIUM 1 Oral 20.0MG UNKNOWN N U 0 20 MG CAPSULE
118058512 11805851 3 SS PRILOSEC OMEPRAZOLE MAGNESIUM 1 Oral 80.0MG UNKNOWN N U 0 80 MG CAPSULE BID
118058512 11805851 4 SS PRILOSEC OMEPRAZOLE MAGNESIUM 1 Oral 40MG IN THE MORNING AND 20MG IN THE EVENING UNKNOWN N U 0
118058512 11805851 5 SS PRILOSEC OMEPRAZOLE MAGNESIUM 1 Oral 2 40 MG CAPSULES, EQUALING 80MG, TWICE A DAY, TOTALING 160 MG UNKNOWN N U 0 CAPSULE
118058512 11805851 6 SS PRILOSEC OMEPRAZOLE MAGNESIUM 1 Oral 40.0MG UNKNOWN N U 0 40 MG BID
118058512 11805851 7 SS PRILOSEC OMEPRAZOLE MAGNESIUM 1 Unknown GENERIC UNKNOWN N U 0
118058512 11805851 8 C REGLAN METOCLOPRAMIDE HYDROCHLORIDE 1 Unknown 0
118058512 11805851 9 C ASPIRIN. ASPIRIN 1 Oral 0 81 MG QD
118058512 11805851 10 C BYSTOLIC NEBIVOLOL HYDROCHLORIDE 1 Oral 2.5MG AS REQUIRED 0 2.5 MG
118058512 11805851 11 C GAVISCON ALUMINUM HYDROXIDEMAGNESIUM CARBONATE 1 Oral 2.5MG AS REQUIRED 0 2.5 MG
118058512 11805851 12 C LIPITOR ATORVASTATIN CALCIUM 1 Oral 2.5MG AS REQUIRED 0 2.5 MG
118058512 11805851 13 C CALCIUM SUPPLEMENT CALCIUM 1 Oral 2.5MG AS REQUIRED 0 2.5 MG

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
118058512 11805851 1 Gastrooesophageal reflux disease
118058512 11805851 2 Gastrooesophageal reflux disease
118058512 11805851 3 Gastrooesophageal reflux disease
118058512 11805851 4 Gastrooesophageal reflux disease
118058512 11805851 5 Gastrooesophageal reflux disease
118058512 11805851 6 Gastrooesophageal reflux disease
118058512 11805851 7 Gastrooesophageal reflux disease
118058512 11805851 9 Stent placement
118058512 11805851 10 Arrhythmia
118058512 11805851 12 Blood cholesterol abnormal

Outcome of event

no results found

Reactions reported

Event ID CASEID DRUG REC ACT PT
118058512 11805851 Depression
118058512 11805851 Discomfort
118058512 11805851 Drug ineffective
118058512 11805851 Gastritis
118058512 11805851 Gastrointestinal motility disorder
118058512 11805851 Hiatus hernia
118058512 11805851 Off label use

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
118058512 11805851 1 201510 0
118058512 11805851 2 1991 0
118058512 11805851 3 1991 201510 0
118058512 11805851 4 1995 201510 0
118058512 11805851 6 2015 0
118058512 11805851 7 2015 0
118058512 11805851 9 2001 0
118058512 11805851 10 1995 0
118058512 11805851 11 1995 0
118058512 11805851 12 1995 0
118058512 11805851 13 1995 0